Degnan, Andrew J.
Ho-Fung, Victor M.
Ahrens-Nicklas, Rebecca C.
Barrera, Christian A.
Serai, Suraj D.
Wang, Dah-Jyuu
Ficicioglu, Can
Article History
Received: 20 March 2019
Accepted: 29 April 2019
First Online: 10 July 2019
Ethics approval and consent to participate
: The Institutional Review Board (local ethics committee) of Children’s Hospital of Philadelphia approved the review and publication of clinical studies, IRB 18-015509.
: De-identified images included in this manuscript are permitted through local ethics committee approval.
: CF has received consulting fees and/or honoraria from Genzyme corporation, Pfizer Inc., and Shire Pharmaceutical, makers of therapies for Gaucher disease. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.